Welcome!
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.
Dr. Sarah Goldberg, from Yale Cancer Center, offers her view on the best way to approach the common scenario of an EGFR mutation or other "driver mutation" being identified during first line chemotherapy. When should we switch treatments?
[powerpress]
Please feel free to offer comments and raise questions in our
discussion forums.
Hi James Anthony, I'm so sorry you are going through this and so very young. It' s true that some people benefit for years with chemo and targeted therapies. With the...
Hi siigs, I'm sorry you're having health issues. They don't sound like pancoast tumor symptoms. A consult with a pulmonologist can help to understand your chest symptoms and work toward alleviating...
Hi Lonnie,
Yes, the info in last year's OncTalk was up to date at that moment. I think it would be well worth the watch along with videos in our 2025...
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.